These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 1326649

  • 1. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
    Palker TJ, Riggs ER, Spragion DE, Muir AJ, Scearce RM, Randall RR, McAdams MW, McKnight A, Clapham PR, Weiss RA.
    J Virol; 1992 Oct; 66(10):5879-89. PubMed ID: 1326649
    [Abstract] [Full Text] [Related]

  • 2. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
    Tallet B, Astier-Gin T, Moynet D, Londos-Gagliardi D, Guillemain B.
    AIDS Res Hum Retroviruses; 2001 Mar 01; 17(4):337-48. PubMed ID: 11242520
    [Abstract] [Full Text] [Related]

  • 3. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
    Desgranges C, Souche S, Vernant JC, Smadja D, Vahlne A, Horal P.
    AIDS Res Hum Retroviruses; 1994 Feb 01; 10(2):163-73. PubMed ID: 8198868
    [Abstract] [Full Text] [Related]

  • 4. HTLV-II-specific antisera raised in rabbits immunized with a synthetic peptide of HTLV-II envelope protein.
    Hayashi K, Ohara N, Fujiwara K, Jeon HJ, Koirala TR, Takahashi K, Akagi T, Tomita N, Miyamoto K.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992 Feb 01; 63(1):37-41. PubMed ID: 1362020
    [Abstract] [Full Text] [Related]

  • 5. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-II (HTLV-II).
    Tanaka Y, Tanaka R, Hoshino H.
    Int J Cancer; 1994 Dec 01; 59(5):655-60. PubMed ID: 7525496
    [Abstract] [Full Text] [Related]

  • 6. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ, Tanner ME, Scearce RM, Streilein RD, Clark ME, Haynes BF.
    J Immunol; 1989 Feb 01; 142(3):971-8. PubMed ID: 2563272
    [Abstract] [Full Text] [Related]

  • 7. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.
    Kariya N, Hayashi K, Hoshino H, Tanaka Y, Koirala TR, Ohara N, Miyamoto K, Akagi T.
    Arch Virol; 1996 Feb 01; 141(3-4):471-80. PubMed ID: 8645089
    [Abstract] [Full Text] [Related]

  • 8. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
    Hernández Marin M, Castellanos Pentón P, Márquez Bocalandro Y, Pozo Peña L, Díaz Navarro J, González López LJ.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):7-12. PubMed ID: 11708768
    [Abstract] [Full Text] [Related]

  • 9. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, Niho Y.
    J Immunol; 1993 Jul 15; 151(2):1013-24. PubMed ID: 7687611
    [Abstract] [Full Text] [Related]

  • 10. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y, Zeng L, Shiraki H, Shida H, Tozawa H.
    J Immunol; 1991 Jul 01; 147(1):354-60. PubMed ID: 1711082
    [Abstract] [Full Text] [Related]

  • 11. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
    Hernández Marin M, Castellanos Pentón P, Márquez Bocalandro Y, Pozo Peña L, Díaz Navarro J, González López LJ.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):1-6. PubMed ID: 11708767
    [Abstract] [Full Text] [Related]

  • 12. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E, Nakamura M, Ohkuma K, Kira J, Tanaka Y, Nakano S, Niho Y.
    J Immunol; 1995 Jan 01; 154(1):399-412. PubMed ID: 7527817
    [Abstract] [Full Text] [Related]

  • 13. De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.
    Sundaram R, Lynch MP, Rawale SV, Sun Y, Kazanji M, Kaumaya PT.
    J Biol Chem; 2004 Jun 04; 279(23):24141-51. PubMed ID: 15060075
    [Abstract] [Full Text] [Related]

  • 14. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
    Palker TJ, Matthews TJ, Langlois A, Tanner ME, Martin ME, Scearce RM, Kim JE, Berzofsky JA, Bolognesi DP, Haynes BF.
    J Immunol; 1989 May 15; 142(10):3612-9. PubMed ID: 2469721
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.
    Inoue Y, Kuroda N, Shiraki H, Sato H, Maeda Y.
    Int J Cancer; 1992 Dec 02; 52(6):877-80. PubMed ID: 1459728
    [Abstract] [Full Text] [Related]

  • 17. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP, Dube S, Spicer TP, Kane TD, Love JL, Saksena NK, Iannone R, Gibbs CJ, Yanagihara R, Dube DK.
    Cancer Res; 1993 Dec 15; 53(24):6067-73. PubMed ID: 8261424
    [Abstract] [Full Text] [Related]

  • 18. Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.
    Londos-Gagliardi D, Jauvin V, Armengaut MH, Astier-Gin T, Goetz M, Huet S, Guillemain BJ.
    AIDS Res Hum Retroviruses; 1999 Jul 01; 15(10):909-20. PubMed ID: 10408728
    [Abstract] [Full Text] [Related]

  • 19. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
    Hadlock KG, Rowe J, Perkins S, Bradshaw P, Song GY, Cheng C, Yang J, Gascon R, Halmos J, Rehman SM, McGrath MS, Foung SK.
    J Virol; 1997 Aug 01; 71(8):5828-40. PubMed ID: 9223472
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.